Flexible Amortized Variational Inference in qBOLD MRI
Authors:
Ivor J. A. Simpson,
Ashley McManamon,
Balázs Örzsik,
Alan J. Stone,
Nicholas P. Blockley,
Iris Asllani,
Alessandro Colasanti,
Mara Cercignani
Abstract:
Streamlined qBOLD acquisitions enable experimentally straightforward observations of brain oxygen metabolism. $R_2^\prime$ maps are easily inferred; however, the Oxygen extraction fraction (OEF) and deoxygenated blood volume (DBV) are more ambiguously determined from the data. As such, existing inference methods tend to yield very noisy and underestimated OEF maps, while overestimating DBV.
This…
▽ More
Streamlined qBOLD acquisitions enable experimentally straightforward observations of brain oxygen metabolism. $R_2^\prime$ maps are easily inferred; however, the Oxygen extraction fraction (OEF) and deoxygenated blood volume (DBV) are more ambiguously determined from the data. As such, existing inference methods tend to yield very noisy and underestimated OEF maps, while overestimating DBV.
This work describes a novel probabilistic machine learning approach that can infer plausible distributions of OEF and DBV. Initially, we create a model that produces informative voxelwise prior distribution based on synthetic training data. Contrary to prior work, we model the joint distribution of OEF and DBV through a scaled multivariate logit-Normal distribution, which enables the values to be constrained within a plausible range. The prior distribution model is used to train an efficient amortized variational Bayesian inference model. This model learns to infer OEF and DBV by predicting real image data, with few training data required, using the signal equations as a forward model.
We demonstrate that our approach enables the inference of smooth OEF and DBV maps, with a physiologically plausible distribution that can be adapted through specification of an informative prior distribution. Other benefits include model comparison (via the evidence lower bound) and uncertainty quantification for identifying image artefacts. Results are demonstrated on a small study comparing subjects undergoing hyperventilation and at rest. We illustrate that the proposed approach allows measurement of gray matter differences in OEF and DBV and enables voxelwise comparison between conditions, where we observe significant increases in OEF and $R_2^\prime$ during hyperventilation.
△ Less
Submitted 7 April, 2022; v1 submitted 11 March, 2022;
originally announced March 2022.
Online information on medical cannabis may rise unrealistic expectations and downplay potential side effects
Authors:
Arthur Cassa Macedo,
André Oliveira Vilela de Faria,
Isabella Bizzi,
Fabrício A. Moreira,
Alessandro Colasanti,
Pietro Ghezzi
Abstract:
There is a growing literature on the potential medical uses of Cannabis sativa and cannabinoid compounds. Although these have only been approved by regulatory agencies for few indications, there is a hype about their possible benefits in a variety of conditions and a large market in the wellness industry. As in many cases patients search for information on cannabis products online, we have analyze…
▽ More
There is a growing literature on the potential medical uses of Cannabis sativa and cannabinoid compounds. Although these have only been approved by regulatory agencies for few indications, there is a hype about their possible benefits in a variety of conditions and a large market in the wellness industry. As in many cases patients search for information on cannabis products online, we have analyzed the information on medical cannabis available on the Internet. Analyzing 176 webpages returned by a search engine, we found that more than half of them were news websites. Pain, epilepsy and multiple sclerosis were the most frequently therapeutic areas mentioned by the webpages, which did not always match those for which there is regulatory approval. Information was also incomplete, with only 22% of the webpages mentioning potential side effects. Health portal websites provided the most complete information. On average, 80% of webpages had a neutral stance on the potential benefits of medical cannabis, with commercial websites having more frequently a positive stance (67%). We conclude that the information that can be found online could raise unrealistic expectations regarding therapeutic areas for which science-based evidence is often still weak.
△ Less
Submitted 5 April, 2020;
originally announced April 2020.
